Recent Advances of Engineered Cell Membrane‐Based Nanotherapeutics to Combat Inflammatory Diseases

Abstract An immune reaction known as inflammation serves as a shield from external danger signals, but an overactive immune system may additionally lead to tissue damage and even a variety of inflammatory disorders. By inheriting biological functionalities and serving as both a therapeutic medication and a drug carrier, cell membrane‐based nanotherapeutics offer the potential to treat inflammatory disorders. To further strengthen the anti‐inflammatory benefits of natural cell membranes, researchers alter and optimize the membranes using engineering methods. This review focuses on engineered cell membrane‐based nanotherapeutics (ECMNs) and their application in treating inflammation‐related diseases. Specifically, this article discusses the methods of engineering cell membranes for inflammatory diseases and examines the progress of ECMNs in inflammation‐targeted therapy, inflammation‐neutralizing therapy, and inflammation‐immunomodulatory therapy. Additionally, the article looks into the perspectives and challenges of ECMNs in inflammatory treatment and offers suggestions as well as guidance to encourage further investigations and implementations in this area.